A5020380947- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Occupational and environmental lung diseases
- Occupational exposure and asthma
- Inhalation and Respiratory Drug Delivery
- Systemic Sclerosis and Related Diseases
- Pulmonary Hypertension Research and Treatments
- Sarcoidosis and Beryllium Toxicity Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Diagnosis and Treatment
- Transplantation: Methods and Outcomes
- Respiratory Support and Mechanisms
- Inflammatory Myopathies and Dermatomyositis
- Medical Imaging and Pathology Studies
- Neonatal Respiratory Health Research
- Neuroscience of respiration and sleep
- Heart Failure Treatment and Management
- Radiation Dose and Imaging
- Childhood Cancer Survivors' Quality of Life
- Tracheal and airway disorders
- Musculoskeletal pain and rehabilitation
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Voice and Speech Disorders
- Cardiac tumors and thrombi
- Clinical practice guidelines implementation
Monash University
2008-2025
The Alfred Hospital
2016-2025
Alfred Health
2020-2025
Central Clinical Hospital
2023
Midatech Pharma (United Kingdom)
2023
School of Clinical Research
2023
University of California, San Francisco
2020-2022
East Suffolk and North Essex NHS Foundation Trust
2022
University of California System
2021
European Society of Intensive Care Medicine
2020
Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding treatment for SSc-ILD are primarily consensus based.
Section:ChooseTop of pageAbstract <<Executive SummaryIntroductionMethodologyFindings/ResultsSummary and Future Direct...ReferencesCITING ARTICLES
Abstract Background and Objective Evidence for the benefit of steroid therapy in acute exacerbations (AEs) idiopathic pulmonary fibrosis (IPF) is limited; however, they remain a cornerstone management other fibrotic interstitial lung diseases. This retrospective observational study assesses effect treatment on in‐hospital mortality patients with exacerbation disease (AE‐FILD) including IPF non‐IPF ILDs. Methods AE‐FILD cases over 10‐year period were filtered using code‐based algorithm...
Abstract Background and Objective Chest x‐ray (CXR) remains a core component of health monitoring guidelines for workers at risk exposure to crystalline silica. There has however been lack evidence regarding the sensitivity CXR detect silicosis in artificial stone benchtop industry workers. Methods Paired high‐resolution computed tomography (HRCT) images were acquired from 110 Blinded clinical diagnosis, each HRCT was independently read by two thoracic radiologists panel seven, accordance...
ABSTRACT Background The fabrication and installation of artificial (engineered) stone countertops is a relatively new cause silicosis. Our aim was to investigate silicosis rates in Victoria, Australia, the association with countertop industry work. Methods Workers' compensation claims for from January 1, 1991 December 31, 2022 were analyzed across 8‐year time periods. Incidence per 100,000 persons calculated by period, age, sex. Additionally, incident cases reported clinical registry...